Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 22 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance for Patients with Advanced Ovarian Cancer with and without HRD FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with Ipilimumab in Patients with Melanoma at High Risk for Recurrence MOST POPULAR October is National Dental Hygiene Month October 1, 2020 How the Cancer Community Can Help Close the Care Gap This... February 4, 2022 Talking With Your Doctor About Negative Emotions During Cancer November 3, 2020 Death Rates from Lung Cancer will Fall Overall in the EU... March 6, 2023 Load more HOT NEWS Identification of Potential Biomarkers for Clinical Benefit Following Dual Neoadjuvant Anti-HER2... FDA Approves Margetuximab for Metastatic HER2-positive Breast Cancer Rookie Cop Saves Infant From Choking Tovorafenib Approved for Some Children with Low-Grade Glioma
